Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
Status:
Completed
Trial end date:
2016-08-07
Target enrollment:
Participant gender:
Summary
This study is an open-label extension (OLE) trial to evaluate the safety and tolerability of
etrolizumab in participants with moderate to severe ulcerative colitis (UC) who were enrolled
in the Phase II Study ABS4986g (NCT01336465) and meet the eligibility criteria for entry in
the OLE study.